Wave Life Sciences (NASDAQ:WVE) said Takeda (NYSE:TAK) has elected not to exercise its option to further develop its Huntington’s disease treatment candidate WVE-003. As a result, Wave (WVE) is now ...
Wake up your nervous system and smash your PRs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results